Koyfin Home > Directory > Health Care > Abbott Laboratories > Net Debt / EBITDA

Abbott Laboratories Net Debt / EBITDA Chart (ABT)

Abbott Laboratories annual/quarterly Net Debt / EBITDA from 2010 to 2020. Net Debt / EBITDA is a measure of leverage for a company by dividing the Debt less Cash on hand vs. EBITDA.
  • Abbott Laboratories Net Debt / EBITDA for the quarter ending September 09, 2020 was $2m a -5.23% decrease of 0m year over year
  • Abbott Laboratories Net Debt / EBITDA for the last 12 months ending September 09, 2020 was $2m a -2.89% decrease of 0m year over year
  • Abbott Laboratories Annual Net Debt / EBITDA for 2019 was $2m a -18.19% decrease of 0m from 2018
  • Abbott Laboratories Annual Net Debt / EBITDA for 2018 was $2m a -42.99% decrease of -1m from 2017
  • Abbott Laboratories Annual Net Debt / EBITDA for 2017 was $3m a 77.00% increase of 2m from 2016
Other Ratios Metrics:
  • Abbott Laboratories Total Debt / Capital for the quarter ending December 12, 2018 was $44m a 5.51% increase of 2m year over year
  • Abbott Laboratories Other Liabilities for the quarter ending September 09, 2018 was $8,407m a -7.41% decrease of -623m year over year
  • Abbott Laboratories Total Debt / Equity for the quarter ending December 12, 2018 was $77m a 9.36% increase of 7m year over year
View Chart On Koyfin

Quarterly ABT Net Debt / EBITDA Data

09/2020$2m
06/2020$2m
03/2020$2m
12/2019$2m
09/2019$2m
06/2019$2m
03/2019$3m
12/2018$2m
09/2018$2m
06/2018$2m

Annual ABT Net Debt / EBITDA Data

2019$2m
2018$2m
2017$3m
2016$1m
2015$1m
2014$1m
2013$0m
2012$1m
2011$2m
2010$1m